Estrogen and extinction of fear memories: Implications for posttraumatic stress disorder treatment

Biological Psychiatry

Volumn 78, Issue 3, 2015, Pages 178-185

  Glover, Ebony M ^a,b   Jovanovic, Tanja ^a   Norrholm, Seth Davin ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNESAW STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Estrogen; Extinction; Fear conditioning; PTSD; Sex differences

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; N METHYL DEXTRO ASPARTIC ACID; PROGESTERONE; SEX HORMONE; STEROID HORMONE; TESTOSTERONE; BIOLOGICAL MARKER;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; BEHAVIOR; ESTROGEN ACTIVITY; ESTROGEN RELEASE; ESTROGEN THERAPY; ESTRUS CYCLE; FEAR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HORMONE ACTION; HUMAN; HYPOTHALAMUS; LONG TERM POTENTIATION; MEMORY; MENSTRUAL CYCLE; NERVE CELL PLASTICITY; NEUROIMAGING; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; DRUG EFFECTS; FEMALE; PSYCHOLOGY; REINFORCEMENT; SEXUAL DEVELOPMENT; STRESS DISORDERS, POST-TRAUMATIC;

BIOMARKERS; ESTROGENS; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MENSTRUAL CYCLE; SEX CHARACTERISTICS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84936929063     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.02.007     Document Type: Review

References (97)

1. McLean CP, Asnaani A, Litz BT, Hofmann SG (2011): Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res 45: 1027-1035.
2. Solomon MB, Herman JP (2009): Sex differences in psychopathology: Of gonads, adrenals, and mental illness. Physiol Behav 97: 250-258.
3. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL (1993): Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 61: 984-991.
4. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995): Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52: 1048-1060.
5. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P (1998): Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55: 626-632.
6. Kilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ (2013): National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress 26: 537-547.
7. Breslau N, Davis GC (1992): Posttraumatic stress disorder in an urban population of young adults: Risk factors for chronicity. Am J Psychiatry 149: 671-675.
8. Laredo SA, Villalon Landeros R, Trainor BC (2014): Rapid effects of estrogens on behavior: Environmental modulation and molecular mechanisms. Front Neuroendocrinol 35: 447-458.
9. Glover EM, Jovanovic T, Mercer KB, Kerley K, Bradley B, Ressler KJ, Norrholm SD (2012): Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biol Psychiatry 72: 19-24.
10. Glover EM, Mercer KB, Norrholm SD, Davis M, Duncan E, Bradley B, et al. (2013): Inhibition of fear is differentially associated with cycling estrogen levels in women. J Psychiatry Neurosci 38: 120-129.
11. Shvil E, Sullivan GM, Schafer S, Markowitz JC, Campeas M, Wager TD, et al. (2014): Sex differences in extinction recall in posttraumatic stress disorder: A pilot fMRI study. Neurobiol Learn Mem 113: 101-108.
12. Earls F (1987): Sex differences in psychiatric disorders: Origins and developmental influences. Psychiatr Dev 5: 1-23.
13. Paus T, Keshavan M, Giedd JN (2008): Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci 9: 947-957.
14. Epperson CN, Kim DR, Bale TL (2014): Estradiol modulation of monoamine metabolism: One possible mechanism underlying sex differences in risk for depression and dementia. JAMA Psychiatry 71: 869-870.
15. Cloitre M, Yonkers KA, Pearlstein T, Altemus M, Davidson KW, Pigott TA, et al. (2004): Women and anxiety disorders: Implications for diagnosis and treatment. CNS Spectr 9: 1-16.
16. Dean C, Kendell RE (1981): The symptomatology of puerperal illnesses. Br J Psychiatry 139: 128-133.
17. Douma SL, Husband C, O'Donnell ME, Barwin BN, Woodend AK (2005): Estrogen-related mood disorders: Reproductive life cycle factors. ANS Adv Nurs Sci 28: 364-375.
18. Pigott T (2003): Anxiety disorders in women. Psychiatr Clin N Am 26: 621-672.
19. Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N (2002): The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep 4: 419-428.
20. Yonkers KA (1997): Anxiety symptoms and anxiety disorders: How are they related to premenstrual disorders? J Clin Psychiatry 58: 62-67.
21. Goldstein JM, Jerram M, Poldrack RA, Ahern T, Kennedy DN, Seidman LJ, Makris N (2005): Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 25: 9309-9316.
22. Goldstein JM, Jerram M, Abbs B, Whitfield-Gabrieli S, Makris N (2010): Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 30: 431-438.
23. Frye CA, Petralia SM, Rhodes ME (2000): Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 67: 587-596.
24. Walf AA, Paris JJ, Frye CA (2009): Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology 34: 909-916.
25. Marcondes FK, Miguel KJ, Melo LL, Spadari-Bratfisch RC (2001): Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol Behav 74: 435-440.
26. Mora S, Dussaubat N, Diaz-Veliz G (1996): Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 21: 609-620.
27. Layton B, Krikorian R (2002): Memory mechanisms in posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 14: 254-261.
28. Davis M (1990): Animal models of anxiety based on classical conditioning: The conditioned emotional response (CER) and fear-potentiated startle effect. Pharmacol Ther 47: 147-165.
29. Rasmusson AM, Charney DS (1997): Animal models of relevance to PTSD. Ann N Y Acad Sci 821: 332-351.
30. Rescorla RA, Wagner AR (1972): A theory of Pavlovian conditioning: Variations in the effectiveness of reinforcement and nonreinforcement. In: Black AH, Prokasy WF, editors. Classical Conditioning II: Current Theory and Research. New York: Appleton-Century-Crofts, 64-99.
31. Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos A, Myers KM, et al. (2009): Posttraumatic stress disorder may be associated with impaired fear inhibition: Relation to symptom severity. Psychiatry Res 167: 151-160.
32. Jovanovic T, Ressler KJ (2010): How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry 167: 648-662.
33. Norrholm SD, Jovanovic T, Olin IW, Sands LA, Karapanou I, Bradley B, Ressler KJ (2011): Fear extinction in traumatized civilians with posttraumatic stress disorder: Relation to symptom severity. Biol Psychiatry 69: 556-563.
34. Briscione MA, Jovanovic T, Norrholm SD (2014): Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Front Psychiatry 5: 88.
35. Maren S, DeOca B, Fanselow MS (1994): Sex differences in hippo-campal long-term potentiation (LTP) and Pavolvian fear conditioning in rats: Positive correlation between LTP and contextual learning. Brain Res 661: 25-34.
36. Pryce CR, Lehmann J, Feldon J (1999): Effect of sex on fear conditioning is similar for context and discrete CS in Wistar, Lewis and Fischer rat strains. Pharmacol Biochem Behav 64: 753-759.
37. Anagnostaras SG, Maren S, DeCola JP, Lane NI, Gale GD, Schlinger BA, Fanselow MS (1998): Testicular hormones do not regulate sexually dimorphic Pavlovian fear conditioning or perforant-path long-term potentiation in adult male rats. Behav Brain Res 92: 1-9.
38. Gupta RR, Sen S, Diepenhorst LL, Rudick CN, Maren S (2001): Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1). Brain Res 888: 356-365.
39. Baran SE, Armstrong CE, Niren DC, Conrad CD (2010): Prefrontal cortex lesions and sex differences in fear extinction and perseveration. Learn Mem 17: 267-278.
40. Jasnow AM, Schulkin J, Pfaff DW (2006): Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone mRNA expression in the central amygdala in female mice. Horm Behav 49: 197-205.
41. Markus EJ, Zecevic M (1997): Sex differences and estrous cycle changes in hippocampus-dependent fear conditioning. Psychobiology 25: 246-252.
42. Myers KM, Davis M (2002): Behavioral and neural analysis of extinction. Neuron 36: 567-584.
43. Rivas-Arancibia S, Vazquez-Pereyra F (1994): Hormonal modulation of extinction responses induced by sexual steroid hormones in rats. Life Sci 54:PL363-PL367.
44. Baran SE, Armstrong CE, Niren DC, Hanna JJ, Conrad CD (2009): Chronic stress and sex differences on the recall of fear conditioning and extinction. Neurobiol Learn Mem 91: 323-332.
45. Chang YJ, Yang CH, Liang YC, Yeh CM, Huang CC, Hsu KS (2009): Estrogen modulates sexually dimorphic contextual fear extinction in rats through estrogen receptor beta. Hippocampus 19: 1142-1150.
46. Lebron-Milad K, Milad MR (2012): Sex differences, gonadal hormones and the fear extinction network: Implications for anxiety disorders. Biol Mood Anxiety Disord 2: 3.
47. Milad MR, Goldstein JM, Orr SP, Wedig MM, Klibanski A, Pitman RK, Rauch SL (2006): Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci 120: 1196-1203.
48. Milad MR, Igoe SA, Lebron-Milad K, Novales JE (2009): Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience 164: 887-895.
49. Milad MR, Zeidan MA, Contero A, Pitman RK, Klibanski A, Rauch SL, Goldstein JM (2010): The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience 168: 652-658.
50. Zeidan MA, Igoe SA, Linnman C, VItalo A, Levine JB, Klibanski A, et al. (2011): Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry 70: 920-927.
51. Wegerer M, Kerschbaum H, Blechert J, Wilhelm FH (2014): Low levels of estradiol are associated with elevated conditioned responding during fear extinction and with intrusive memories in daily life. Neurobiol Learn Mem 116: 145-154.
52. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB, et al. (2000): Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: A functional MRI study. Biol Psychiatry 47: 769-776.
53. Shin LM, Wright CI, Cannistraro PA, Wedig MM, McMullin K, Martis B, et al. (2005): A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 62: 273-281.
54. Milad MG, Quirk GJ (2002): Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420: 70-74.
55. Phelps EA, Delgado MR, Nearing KI, LeDoux JE (2004): Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 43: 897-905.
56. Milner TA, Ayoola K, Drake CT, Herrick SP, Tabori NE, McEwen BS, et al. (2005): Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol 491: 81-95.
57. Ostlund H, Keller E, Hurd YL (2003): Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 1007: 54-63.
58. Osterlund MK, Hurd YL (2001): Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 64: 251-267.
59. Weiser MJ, Foradori CD, Handa RJ (2008): Estrogen receptor beta in the brain: From form to function. Brain Res Rev 57: 309-320.
60. Gillies GE, McArthur S (2010): Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol Rev 62: 155-198.
61. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF (2002): Estrogen receptor-alpha distribution in the human hypothalamus in relation to sex and endocrine status. J Comp Neurol 454: 115-139.
62. Inagaki T, Gautreaux C, Luine V (2010): Acute estrogen treatment facilitates recognition memory consolidation and alters monoamine levels in memory-related brain areas. Horm Behav 58: 415-426.
63. Luine VN, Frankfurt M (2012): Estrogens facilitate memory processing through membrane mediated mechanisms and alterations in spine density. Front Neuroendocrinol 33: 388-402.
64. Kramar EA, Babayan AH, Gall CM, Lynch G (2013): Estrogen promotes learning-related plasticity by modifying the synaptic cytos-keleton. Neuroscience 239: 3-16.
65. Srivastava DP, Woolfrey KM, Evans PD (2013): Mechanisms underlying the interactions between rapid estrogenic and BDNF control of synaptic connectivity. Neuroscience 239: 17-33.
66. Romeo RD, McCarthy JB, Wang A, Milner TA, McEwen BS (2005): Sex differences in hippocampal estradiol-induced N-methyl-D-aspartic acid binding and ultrastructural localization of estrogen receptor-alpha. Neuroendocrinology 81: 391-399.
67. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R, et al. (2008): Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 11: 334-343.
68. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG (2005): Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 25: 5066-5078.
69. Mermelstein PG (2009): Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J Neuroendocrinol 21: 257-262.
70. Scharfman HE, MacLusky NJ (2006): Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: Complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuro-endocrinol 27: 415-435.
71. Soliman F, Glatt CE, Bath KG, Levita L, Jones RM, Pattwell SS, et al. (2010): A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327: 863-866.
72. Bryant RA, Felmingham KL, Silove D, Creamer M, O'Donnell M, McFarlane AC (2011): The association between menstural cycle and traumatic memories. J Affect Disord 131: 398-401.
73. Cahill L (2003): Sex-related influences on the neurobiology of emotionally influenced memory. Ann N Y Acad Sci 985: 163-173.
74. Felmingham K, Williams LM, Kemp AH, Liddell B, Falconer EM, Peduto A, Bryant R (2010): Neural responses to masked fear faces: Sex differences and trauma exposure in posttraumatic stress disorder. J Abnorm Psychol 119: 241-247.
75. Butler T, Pan H, Epstein J, Protopopescu X, Tuescher O, Goldstein M, et al. (2005): Fear-related activity in subgenual anterior cingulate differs between men and women. Neuroreport 16: 1233-1236.
76. Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, et al. (2004): Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41: 401-406.
77. Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C (2007): Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharma-cology 32: 2190-2198.
78. Glover EM, Phifer JE, Crain DF, Norrholm SD, Davis M, Bradley B, et al. (2011): Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures. Depress Anxiety 28: 1058-1066.
79. Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ (2010): Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety 27: 244-251.
80. Inslicht SS, Metzler TJ, Garcia NM, Pineles SL, Milad MR, Orr SP, et al. (2013): Sex differences in fear conditioning in posttraumatic stress disorder. J Psychiatr Res 47: 64-71.
81. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, et al. (2011): Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470: 492-497.
82. Stevens JS, Almli LM, Fani N, Gutman DA, Bradley B, Norrholm SD, et al. (2014): PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proc Natl Acad Sci U S A 111: 3158-3163.
83. Almli LM, Mercer KB, Kerley K, Feng H, Bradley B, Conneely KN, Ressler KJ (2013): ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am J Med Genet B Neuropsychiatr Genet 162B: 262-272.
84. Jovanovic T, Norrholm SD, Davis J, Mercer KB, Almli L, Nelson A, et al. (2012): PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children. Mol Psychiatry 18: 742-743.
85. Uddin M, Chang SC, Zhang C, Ressler K, Mercer KB, Galea S, et al. (2013): Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment. Depress Anxiety 30: 251-258.
86. Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, et al. (2012): No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry 17: 239-241.
87. Graham BM, Milad MR (2013): Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry 73: 371-378.
88. Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B, et al. (2014): A randomized, double-blind evaluation of d-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. Am J Psychiatry 171: 640-648.
89. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000): Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol 183: 414-420.
90. Soares CN, Almeida OP, Joffe H, Cohen LS (2001): Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58: 529-534.
91. Ferree NK, Wheeler M, Cahill L (2012): The influence of emergency contraception on post traumatic stress symptoms following sexual assault. J Forensic Nurs 8: 122-130.
92. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, et al. (2004): Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61: 1136-1144.
93. Monfils M-H, Cowansage KK, Klann E, LeDoux JE (2009): Extinction-reconsolidation boundaries: Key to persistent attenuation of fear memories. Science 324: 951-955.
94. Schiller D, Monfils M-H, Raio CM, Johnson DC, LeDoux JE, Phelps EA (2009): Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463: 49-53.
95. Warren VT, Anderson KM, Kwon C, Bosshardt L, Jovanovic T, Bradley B, Norrholm SD (2014): Human fear extinction and return of fear using reconsolidation update mechanisms: The contribution of on-line expectancy ratings. Neurobiol Learn Mem 113: 165-173.
96. Parke A, Abernethy K (2008): Hormone replacement therapy: Risks and benefits. Nurse Prescribing 6: 433-439.
97. Rubinow DR, Girdler SS (2011): Hormones, heart disease, and health: Individualized medicine versus throwing the baby out with the bathwater. Depress Anxiety 28:E1-E15.